ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728553 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728553; 2) Community: the network communities that were significantly associated with the response to NSC 728553; 3) Molecule: the relationships between components within communities and NSC 728553; 4) MDR: the compounds that were significantly associated with the NSC 728553.

NSC Compound Enrichment Correlation
NSC 679516 Null 0.0348993771550531 0.19042492
NSC 684906 Null 0.0348993771550531 0.21050801
NSC 688228 Null 0.0348993771550531 0.12998059
NSC 6926 Null 0.0348993771550531 0.11544853
NSC 718781 Erlotinib hydrochloride 0.0348993771550531 -0.23576313
NSC 720134 Null 0.0348993771550531 -0.1604594
NSC 720495 Null 0.0348993771550531 -0.059627287
NSC 726217 Combretastatin A4-analogue 0.0348993771550531 0.29457999
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0348993771550531 0.21268797
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0348993771550531 -0.031581646
Total:66  Current:39    [First] [Prev] [Next] [Last]